The lymphocyte homing receptors: gatekeepers of the multistep paradigm.

Abstract:

PURPOSE OF REVIEW:Lymphocyte trafficking is regulated by adhesion molecules mediating the initial shear-resistant binding of circulating cells to target tissue endothelium (Step 1). This review focuses on the current and emerging perspectives of the biology of these 'homing receptors.' RECENT FINDINGS:The conventional multistep paradigm holds that leukocyte migration represents a cascade of events, initiated by tethering and rolling interactions of leukocytes on the endothelial surface (Step 1). These interactions are indispensable, required to dampen velocities sufficiently to allow cells to sense the local chemokines and/or other inflammatory signals resulting in activation of integrin adhesiveness (Step 2), with ensuing firm adherence on the vessel wall (Step 3) followed by endothelial transmigration (Step 4). Mechanistic studies now suggest that some effectors of Step 1 interactions themselves activate integrin adhesiveness and trigger transmigration--in some cases by forming complexes with integrins--thus bypassing the need for chemokine signaling. These findings force a reconsideration of the multistep paradigm, and shift focus now to identifying all relevant effectors of Step 1 interactions using adherence assays performed under shear stress to mimic the dynamic conditions of blood flow. SUMMARY:Recent findings suggest that homing receptors are not merely molecular brakes. The cross-talk among the homing receptors and integrins opens a new 'avenue' to lymphocyte migration, suggesting that homing receptors may be sufficient alone, in some cases, to perform the function the name implies.

journal_name

Curr Opin Hematol

authors

Sackstein R

doi

10.1097/01.moh.0000177827.78280.79

keywords:

subject

Has Abstract

pub_date

2005-11-01 00:00:00

pages

444-50

issue

6

eissn

1065-6251

issn

1531-7048

pii

00062752-200511000-00003

journal_volume

12

pub_type

杂志文章,评审
  • Multiple myeloma and chronic lymphocytic leukemia.

    abstract::Much progress has been made in delineating the pathogenesis of multiple myeloma and chronic lymphocytic leukemia. The cell of origin in both diseases has been better defined, which has led to important clinical treatments. For myeloma, reduction of tumor burden in autografts has been accomplished and been associated w...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603040-00007

    authors: Vescio R,Rosen L,Schmulbach E,Berenson J

    更新日期:1996-07-01 00:00:00

  • Retrievable vena cava filters: a review.

    abstract:PURPOSE OF REVIEW:To examine the current literature regarding retrievable inferior vena cava filters and to discuss the appropriate indications for their clinical use. RECENT FINDINGS:Permanent filters have been shown to be effective, but have a number of long-term complications such as filter thrombosis or migration....

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000239707.63168.ee

    authors: Imberti D,Ageno W,Carpenedo M

    更新日期:2006-09-01 00:00:00

  • The metabolism of lymphomas.

    abstract:PURPOSE OF REVIEW:Cellular to animal to human studies are shedding light on metabolic pathways that contribute to sustaining lymphomagenesis. Old players with new metabolic tricks and new metabolic players come into the scene. The purpose of this review is to discuss the recent advances made in the field of lymphoma me...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283623d16

    authors: Calvo-Vidal MN,Cerchietti L

    更新日期:2013-07-01 00:00:00

  • Toll-like receptors and innate immunity in gut homeostasis and pathology.

    abstract:PURPOSE OF REVIEW:Immune responses to commensal bacteria and resulting chronic inflammation are hallmarks of inflammatory bowel disease. Considerable evidence has accumulated to suggest that innate immune defense mechanisms interact with pro-inflammatory pathways and exacerbate or perhaps even initiate development of i...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200701000-00010

    authors: Michelsen KS,Arditi M

    更新日期:2007-01-01 00:00:00

  • Matched sibling donor hematopoietic stem cell transplantation for thalassemia.

    abstract:PURPOSE OF REVIEW:Bone marrow transplantation is the only curative treatment for severe thalassemia. Since its successful first report in 1981, more than 4000 patients with this disease worldwide underwent bone marrow transplantation. The purpose of this review is to update the most recent reports of matched sibling do...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000286

    authors: Issaragrisil S,Kunacheewa C

    更新日期:2016-11-01 00:00:00

  • Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection.

    abstract::Matching for human leukocyte antigen (HLA) loci is the most crucial factor in the selection of bone marrow donors. The techniques utilized to assign HLA type have evolved significantly since the application of polymerase chain reaction-based methodologies. A significant challenge for DNA typing methodologies is to be ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199811000-00012

    authors: Little AM,Marsh SG,Madrigal JA

    更新日期:1998-11-01 00:00:00

  • Advances in the immunotherapy of hematologic malignancies: cellular and humoral approaches.

    abstract::Therapy with unconjugated monoclonal antibodies (mAbs) and radiolabeled mAbs has shown activity in patients with B-cell non-Hodgkin's lymphoma and leukemia. Drug-conjugated mAbs are active in relapsed leukemia. Using these new agents with and after chemotherapy induces a high rate of remission, but this needs to be co...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199907000-00005

    authors: Maloney DG

    更新日期:1999-07-01 00:00:00

  • New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases.

    abstract:PURPOSE OF REVIEW:Intravenous immunoglobulin (IVIg) is an effective treatment for an increasing number of autoimmune and inflammatory conditions. However, IVIg continues to be limited by problems of potential shortages and cost. A number of mechanisms have been described for IVIg, which have been captured in newly emer...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章

    doi:10.1097/MOH.0000000000000609

    authors: Norris PAA,Kaur G,Lazarus AH

    更新日期:2020-11-01 00:00:00

  • Purging marrow or peripheral blood stem cells for autografting.

    abstract::Myeloablative therapy followed by autologous bone marrow or peripheral blood stem cell rescue is an alternative therapeutic option for patients who are not candidates for allogeneic transplantation due to the lack of an appropriate HLA-matched donor or to advanced age. It allows therapy to be administered that is of c...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199704060-00011

    authors: Hammert LC,Ball ED

    更新日期:1997-11-01 00:00:00

  • Molecular approaches to blood group identification.

    abstract::Allogeneic barriers to transfusion are caused by differences between those portions of the donor and recipient genomes that define the antigenicity and immune response to the transfused cells. Historically, a blood group antigen was identified when an immune response (alloantibody) was detected by hemagglutination in ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200203000-00012

    authors: Reid ME,Lomas-Francis C

    更新日期:2002-03-01 00:00:00

  • The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia.

    abstract::The advent of better diagnostic tools, molecular techniques, and cytokine therapies have come together at the end of the 20th century to provide an improved outlook for patients with autoimmune neutropenia. Severe chronic neutropenia is no longer idiopathic in most cases, and growth factor therapy can be safely offere...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200105000-00007

    authors: Smith MA,Smith JG

    更新日期:2001-05-01 00:00:00

  • Bleeding complications with platelet glycoprotein IIb/IIIa receptor antagonists.

    abstract::Platelet glycoprotein (GP) IIb/IIIa receptor antagonists are being used with increasing frequency in the settings of percutaneous coronary interventions and acute ischemic syndromes. The development of bleeding complications following GPIIb/IIIa blockade represents a significant limitation to its effectiveness. Baseli...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199909000-00011

    authors: Madan M,Blankenship JC,Berkowitz SD

    更新日期:1999-09-01 00:00:00

  • Is cure for chronic myeloid leukemia possible in the tyrosine kinase inhibitors era?

    abstract:PURPOSE OF REVIEW:The advent of tyrosine kinase inhibitors (TKI) has remarkably changed the treatment of chronic myeloid leukemia (CML). Patients treated in chronic phase can enjoy an expected survival similar to the general population. In the last few years we have found that some patients with an excellent therapeuti...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000224

    authors: Bansal A,Radich J

    更新日期:2016-03-01 00:00:00

  • Human stem cell assays in immune-deficient mice.

    abstract::Much of our understanding of the organization of the cells that comprise the hematopoietic system and the cellular and molecular mechanisms that regulate their development is derived from mouse models. However, knowledge of the human hematopoietic system and identification of human stem cells have, until recently, bee...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603060-00002

    authors: Dick JE

    更新日期:1996-11-01 00:00:00

  • Acute graft-versus-host disease: new treatment strategies.

    abstract:PURPOSE OF REVIEW:Graft-versus-host disease (GVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT), despite improvements in our understanding of its pathophysiology as well as the generation of new monoclonal antibodies, immunomodulatory chemotherapy, cellular ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283319a6f

    authors: Paczesny S,Choi SW,Ferrara JL

    更新日期:2009-11-01 00:00:00

  • The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease.

    abstract::Platelet aggregation, a process mediated by GP IIb-IIIa, is responsible for the occlusive events in thrombosis: indeed, GP IIb-IIIa antagonists are effective in blocking arterial thrombosis. Recent studies have suggested that activated platelets and platelet thrombi can contribute significantly to the initiation and p...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200309000-00006

    authors: Prasad KS,Andre P,Yan Y,Phillips DR

    更新日期:2003-09-01 00:00:00

  • The role of PI3K/protein kinase B (PKB/c-akt) in migration and homing of hematopoietic stem and progenitor cells.

    abstract:PURPOSE OF REVIEW:Hematopoietic stem cell (HSC) transplantation is the most powerful treatment modality for a variety of hematological disorders. Successful hematopoietic recovery after transplantation depends on optimal homing of HSCs to the bone marrow and subsequent lodging in the HSC niche. The molecular mechanisms...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32834760e5

    authors: Buitenhuis M

    更新日期:2011-07-01 00:00:00

  • Polycythemia vera and other primary polycythemias.

    abstract:PURPOSE OF REVIEW:Diagnosis and therapy of polycythemia vera are controversial since the molecular basis of polycythemia vera remains unknown. Distinguishing between polycythemia vera and other polycythemic disorders can be very challenging. The purpose of this review is to discuss the recent progress in this area and ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000154029.05396.d2

    authors: Prchal JT

    更新日期:2005-03-01 00:00:00

  • Chronic idiopathic neutropenias and severe congenital neutropenia.

    abstract:PURPOSE OF REVIEW:Chronic idiopathic and severe congenital neutropenias are rare disorders for which recent discoveries have highlighted mechanisms and consequences. RECENT FINDINGS:An inflammatory bone marrow milieu has been shown to be a major contributor to the pathophysiology of chronic idiopathic neutropenia. Act...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3282f172d3

    authors: Palmblad J,Papadaki HA

    更新日期:2008-01-01 00:00:00

  • Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia.

    abstract::When a new product with huge clinical potential explodes on the scene, the hope is that the benefits far outweigh the risks in long-term administration. After 10 years of clinical use, granulocyte colony-stimulating factor (G-CSF) has lived up to that promise so far. In the context of severe chronic neutropenia, more ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199704030-00011

    authors: Freedman MH

    更新日期:1997-05-01 00:00:00

  • Update on thrombopoietin in preclinical and clinical trials.

    abstract::Thrombopoietin, also termed the c-Mpl ligand, is a lineage-dominant hematopoietic factor that primarily regulates megakaryopoiesis and thrombopoiesis. Treatment of normal animals with recombinant human megakaryocyte growth and development factor, a truncated molecule of the c-Mpl ligand, which is modified with polyeth...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199805000-00009

    authors: Miyazaki H

    更新日期:1998-05-01 00:00:00

  • Ras-related GTP-binding proteins and leukocyte signal transduction.

    abstract::Many aspects of leukocyte function are regulated by both heterotrimeric and Ras-related GTP-binding proteins, but there is little definite information about their roles in the specialized processes utilized by leukocytes for cell killing. Recent progress in understanding the regulation of the phagocyte NADPH oxidase b...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章

    doi:

    authors: Bokoch GM,Knaus UG

    更新日期:1994-01-01 00:00:00

  • The modern landscape of transfusion-related iatrogenic Creutzfeldt-Jakob disease and blood screening tests.

    abstract::The idea that blood in naturally occurring transmissible spongiform encephalopathies is not infectious has imploded in the face of recent transmissions from the blood of naturally occurring scrapie in sheep and of variant Creutzfeldt-Jakob disease in humans. Although donor exclusion criteria ensure that the number of ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000143393.49202.f0

    authors: Brown P,Cervenakova L

    更新日期:2004-09-01 00:00:00

  • Thrombocytopenia in liver disease.

    abstract:PURPOSE OF REVIEW:To evaluate recent findings in the multifaceted pathophysiological mechanisms underlying thrombocytopenia in patients with chronic liver disease and to assess its therapeutic management. RECENT FINDINGS:Antiplatelet antibodies, despite being observed rather frequently in patients with chronic viral l...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32830a9746

    authors: Giannini EG,Savarino V

    更新日期:2008-09-01 00:00:00

  • Problems and prospects in gene therapy for hemophilia.

    abstract::The aim of gene therapy for hemophilia is the stable introduction and expression of a gene encoding functional blood coagulation factor VIII or IX. Although there are as yet no published studies demonstrating long-term expression of therapeutic levels in large animal models of the disease, there have been several repo...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199809000-00003

    authors: Herzog RW,High KA

    更新日期:1998-09-01 00:00:00

  • Fibroblast growth factor signaling promotes physiological bone remodeling and stem cell self-renewal.

    abstract:PURPOSE OF REVIEW:Fibroblast growth factor (FGF) signaling activates many bone marrow cell types, including various stem cells, osteoblasts, and osteoclasts. However, the role of FGF signaling in regulation of normal and leukemic stem cells is poorly understood. This review highlights the physiological roles of FGF sig...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283606162

    authors: Itkin T,Kaufmann KB,Gur-Cohen S,Ludin A,Lapidot T

    更新日期:2013-05-01 00:00:00

  • Optimal dosing and triggers for prophylactic use of platelet transfusions.

    abstract::Despite the reliance on platelet transfusion support in patients receiving myeloablative therapy, controversies surround platelet transfusion practices. These include the appropriate platelet dose and the threshold at which prophylactic platelet transfusions will be most effective. These issues bear directly on patien...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199911000-00015

    authors: Rinder HM,Arbini AA,Snyder EL

    更新日期:1999-11-01 00:00:00

  • Sirtuin 1, stem cells, aging, and stem cell aging.

    abstract:PURPOSE OF REVIEW:New discoveries focused on mitochondrial metabolism and gene silencing and their regulation by the sirtuin family of protein deacetylases is stimulating new ideas on how to improve geriatric medicine. Information about sertuins in stem cell biology is scarce. We consider recent information on sirtuin ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283043819

    authors: Mantel C,Broxmeyer HE

    更新日期:2008-07-01 00:00:00

  • Immunotherapy for thrombotic thrombocytopenic purpura.

    abstract:PURPOSE OF REVIEW:This review focuses on recent advances in the use of immune-based therapy to treat patients with refractory and relapsing acquired thrombotic thrombocytopenic purpura. RECENT FINDINGS:Advances in understanding of the pathophysiology of idiopathic thrombotic thrombocytopenic purpura have provided the ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000170534.33517.99

    authors: Cataland SR,Wu HM

    更新日期:2005-09-01 00:00:00

  • The clinical consequences of neutrophil priming.

    abstract:PURPOSE OF REVIEW:Neutrophils priming has been long studied in vitro. Recent studies describe it in vivo. In pathophysiological conditions, complex, heterogeneous characteristics of priming are described in the last few years. RECENT FINDINGS:Priming can occur systemically when insults such as sepsis or trauma result ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000471

    authors: Vogt KL,Summers C,Condliffe AM

    更新日期:2019-01-01 00:00:00